person · Reporting owner

EVAN DANA L

Disclosed activity across 8 companies

Tapewire entity: 34778
SEC CIK: 0001204818

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
BOX INCBOX · Entity 3932	Director	September 15, 2026	September 16, 2026
Criteo S.A.CRTO · Entity 291	Director	May 16, 2017	May 18, 2017
Huckleberry.ai, Inc.DOMO · Entity 6423	Director	June 02, 2022	June 03, 2022
UPWORK, INCUPWK · Entity 4876	Director	June 04, 2026	June 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BOX INC

Report date September 15, 2026 · Filed September 16, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	115,739	Reported balance After 2026-09-15 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-09-15 · Sale · Disposed 6,158 · Balance 115,739 F1: Certain of these shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer subject to the applicable vesting schedule and the Reporting Person's continuous service through each such date.

Filing footnotes · ownership attribution and instrument terms

F1: Certain of these shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer subject to the applicable vesting schedule and the Reporting Person's continuous service through each such date.

Criteo S.A.

Report date May 16, 2017 · Filed May 18, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	0	Last balance in matching sequence After 2017-05-17 transaction · row 6 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 6 source rows Row 1 · 2017-05-16 · Exercise / conversion · Acquired 3,866 · Balance 3,866 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2: The exercise price of the non-employee warrant is 41.02 euros. The U.S. dollar equivalent of the exercise price is $44.82 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926) F3: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Row 2 · 2017-05-16 · Sale · Disposed 3,866 · Balance 0 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.80 to $52.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote (6) to this Form 4. F3: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Row 3 · 2017-05-16 · Exercise / conversion · Acquired 10,300 · Balance 10,300 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.54 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926) F3: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Row 4 · 2017-05-16 · Sale · Disposed 10,300 · Balance 0 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.80 to $52.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote (6) to this Form 4. F3: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Row 5 · 2017-05-17 · Exercise / conversion · Acquired 10,000 · Balance 10,000 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.54 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926) F3: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Row 6 · 2017-05-17 · Sale · Disposed 10,000 · Balance 0 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F6: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.60 to $44.66, inclusive. F3: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").
Non-employee Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $44.82 · Expires 2025-03-19	Direct	3,864	Reported balance After 2017-05-16 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2017-05-16 · Exercise / conversion · Disposed 3,866 · Balance 3,864 F2: The exercise price of the non-employee warrant is 41.02 euros. The U.S. dollar equivalent of the exercise price is $44.82 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926) F7: One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").
Non-employee Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.54 · Expires 2023-03-06	Direct	10,300	Reported balance After 2017-05-16 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2017-05-16 · Exercise / conversion · Disposed 10,300 · Balance 10,300 F5: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.54 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926) F7: One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").
Non-employee Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.54 · Expires 2023-03-06	Direct	300	Reported balance After 2017-05-17 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2017-05-17 · Exercise / conversion · Disposed 10,000 · Balance 300 F5: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.54 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926) F7: One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Filing footnotes · ownership attribution and instrument terms

F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2: The exercise price of the non-employee warrant is 41.02 euros. The U.S. dollar equivalent of the exercise price is $44.82 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926)

F3: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.80 to $52.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote (6) to this Form 4.

F5: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.54 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926)

F6: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.60 to $44.66, inclusive.

F7: One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter.

Huckleberry.ai, Inc.

Report date June 02, 2022 · Filed June 03, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class B Common StockSEC Table I · non-derivative	Direct	19,278	Reported balance After 2022-06-02 transaction · row 1 1 source row Row 1 · 2022-06-02 · Grant · Acquired 5,049 · Balance 19,278 F1: The shares are represented by restricted stock units (each, an "RSU"). Each RSU represents the Reporting Person's right to receive one share of Class B Common Stock of the Issuer, subject to the applicable vesting schedule. In the event the Reporting Person ceases to be a service provider, the unvested RSUs will be canceled by the Issuer.

Filing footnotes · ownership attribution and instrument terms

F1: The shares are represented by restricted stock units (each, an "RSU"). Each RSU represents the Reporting Person's right to receive one share of Class B Common Stock of the Issuer, subject to the applicable vesting schedule. In the event the Reporting Person ceases to be a service provider, the unvested RSUs will be canceled by the Issuer.

UPWORK, INC

Report date June 04, 2026 · Filed June 08, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	56,835	Reported balance After 2026-06-04 transaction · row 1 1 source row Row 1 · 2026-06-04 · Grant · Acquired 20,880 · Balance 56,835 F1: Represents an award of restricted stock units ("RSUs"). 100% of the total number of RSUs shall vest in full on the earlier of (a) the date immediately prior to the Issuer's 2027 annual meeting of stockholders and (b) June 4, 2027, in each case subject to the continuing service of the Reporting Person through such date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of restricted stock units ("RSUs"). 100% of the total number of RSUs shall vest in full on the earlier of (a) the date immediately prior to the Issuer's 2027 annual meeting of stockholders and (b) June 4, 2027, in each case subject to the continuing service of the Reporting Person through such date.

Past disclosures · reporting ended (4)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Everyday Health, Inc.

Report date December 03, 2016 · Filed December 06, 2016

Section 16 reporting ended · disclosed 2016-12-06. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Ending reported balance After 2016-12-05 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2016-12-03 · Other · Disposed 2,008 · Balance 16,375 F1: Disposed of pursuant to a cash tender offer conducted in accordance with the Agreement and Plan of Merger (the "Merger Agreement"), dated October 21, 2016, among the Issuer, Ziff Davis, LLC, a Delaware limited liability company (the "Parent"), Project Echo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") and j2 Global, Inc. in exchange for cash consideration of $10.50 per share, without interest and less any applicable tax withholding. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). Row 2 · 2016-12-05 · Disposition to issuer · Disposed 16,375 · Balance 0 F2: Pursuant to the terms of the award, the vesting of restricted stock units for an aggregate of 16,375 shares was accelerated in connection with the Merger. Pursuant to the terms of the Merger Agreement, these accelerated restricted stock units were cancelled and converted into the right to receive cash consideration of $10.50 per share (without interest and less any applicable tax withholding).
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.68	Direct	Reported balance After 2016-12-05 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2016-12-05 · Disposition to issuer · Disposed 20,333 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding).
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.35	Direct	Reported balance After 2016-12-05 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2016-12-05 · Disposition to issuer · Disposed 23,333 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding).
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.87	Direct	Reported balance After 2016-12-05 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2016-12-05 · Disposition to issuer · Disposed 23,333 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding).
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.59	Direct	Reported balance After 2016-12-05 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2016-12-05 · Disposition to issuer · Disposed 83,333 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding).

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to a cash tender offer conducted in accordance with the Agreement and Plan of Merger (the "Merger Agreement"), dated October 21, 2016, among the Issuer, Ziff Davis, LLC, a Delaware limited liability company (the "Parent"), Project Echo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") and j2 Global, Inc. in exchange for cash consideration of $10.50 per share, without interest and less any applicable tax withholding. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger").

F2: Pursuant to the terms of the award, the vesting of restricted stock units for an aggregate of 16,375 shares was accelerated in connection with the Merger. Pursuant to the terms of the Merger Agreement, these accelerated restricted stock units were cancelled and converted into the right to receive cash consideration of $10.50 per share (without interest and less any applicable tax withholding).

F3: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding).

MOMENTIVE GLOBAL INC.

Report date May 31, 2023 · Filed June 02, 2023

Section 16 reporting ended · disclosed 2023-06-02. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2023-05-31 transaction · row 1 1 source row Row 1 · 2023-05-31 · Disposition to issuer · Disposed 39,364 · Balance 0 F1: At the effective time of the merger contemplated by the Agreement and Plan of Merger, dated March 13, 2023, among Mercury Bidco LLC, Mercury Merger Sub, Inc. and Momentive Global Inc. (the "Company"), each issued and outstanding share of the Company's common stock was cancelled and converted into the right to receive an amount equal to $9.46 in cash.

Filing footnotes · ownership attribution and instrument terms

F1: At the effective time of the merger contemplated by the Agreement and Plan of Merger, dated March 13, 2023, among Mercury Bidco LLC, Mercury Merger Sub, Inc. and Momentive Global Inc. (the "Company"), each issued and outstanding share of the Company's common stock was cancelled and converted into the right to receive an amount equal to $9.46 in cash.

Nextdoor Holdings, Inc.

Report date June 08, 2026 · Filed June 10, 2026

Section 16 reporting ended · disclosed 2026-06-10. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	152,740	Reported balance After 2026-06-08 transaction · row 1 1 source row Row 1 · 2026-06-08 · Exercise / conversion · Acquired 106,707 · Balance 152,740
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2026-06-08 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-06-08 · Exercise / conversion · Disposed 106,707 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2: The entire RSU award vested or vests on the earlier of the (a) date of the 2026 annual meeting of the Issuer's stockholders or (b) June 10, 2026, in each case subject to the reporting person's continued service to Issuer through the applicable vesting date. F3: These RSUs do not expire; they either vest or are cancelled prior to the vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2: The entire RSU award vested or vests on the earlier of the (a) date of the 2026 annual meeting of the Issuer's stockholders or (b) June 10, 2026, in each case subject to the reporting person's continued service to Issuer through the applicable vesting date.

F3: These RSUs do not expire; they either vest or are cancelled prior to the vesting date.

PROOFPOINT INC

Report date August 31, 2021 · Filed August 31, 2021

Section 16 reporting ended · disclosed 2021-08-31. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2021-08-31 transaction · row 1 1 source row Row 1 · 2021-08-31 · Disposition to issuer · Disposed 14,461 · Balance 0 F1: On April 25, 2021, Proofpoint, Inc. (the "Company") entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement") with Project Kafka Parent, LLC ("Parent") and Project Kafka Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the "Effective Time"), were canceled and converted automatically into the right to receive $176.00 in cash. F2: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F3: Includes 1,499 Unvested Company RSUs.
Non-qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.53 · Expires 2023-06-10	Direct	0	Reported balance After 2021-08-31 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2021-08-31 · Disposition to issuer · Disposed 7,500 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each vested Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $176.00 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. F5: The stock option is fully vested.

Filing footnotes · ownership attribution and instrument terms

F1: On April 25, 2021, Proofpoint, Inc. (the "Company") entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement") with Project Kafka Parent, LLC ("Parent") and Project Kafka Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the "Effective Time"), were canceled and converted automatically into the right to receive $176.00 in cash.

F2: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates.

F3: Includes 1,499 Unvested Company RSUs.

F4: Pursuant to the Merger Agreement, at the Effective Time, each vested Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $176.00 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option.

F5: The stock option is fully vested.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 10, 2019 Filed May 10, 2019 21:24 UTC	PROOFPOINT INC PFPT · Entity 135877	Exercise / conversionNon-qualified stock option (right to buy) · Derivative	854	$0.00 Strike: $4.88	$0.00	Disclosure SEC source: 0001567619-19-010457 · doc1.xml · derivative · entry 2 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,646 Underlying: Common Stock · 854 shares Expires 2020-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise occurred at the direction and for the benefit of the Reporting Person's former spouse pursuant to a domestic relations order as defined in the Internal Revenue Code or Title I of the Employee Retirement Income Security Act (or the rules thereunder), and therefore did not result in an acquisition of beneficial ownership of the underlying shares of the Issuer's common stock by the Reporting Person. F3 · derivative.exercise_date: The stock option is immediately exercisable in full. Read SEC document
May 10, 2019 Filed May 10, 2019 21:24 UTC	PROOFPOINT INC PFPT · Entity 135877	Exercise / conversionCommon Stock	854	$4.88	$4,167.52	Disclosure SEC source: 0001567619-19-010457 · doc1.xml · nonDerivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise occurred at the direction and for the benefit of the Reporting Person's former spouse pursuant to a domestic relations order as defined in the Internal Revenue Code or Title I of the Employee Retirement Income Security Act (or the rules thereunder), and therefore did not result in an acquisition of beneficial ownership of the underlying shares of the Issuer's common stock by the Reporting Person. F1 · shares: This exercise occurred at the direction and for the benefit of the Reporting Person's former spouse pursuant to a domestic relations order as defined in the Internal Revenue Code or Title I of the Employee Retirement Income Security Act (or the rules thereunder), and therefore did not result in an acquisition of beneficial ownership of the underlying shares of the Issuer's common stock by the Reporting Person. F2 · balance_after: The Reporting Person no longer reports as beneficially owned any securities owned by her former spouse, and therefore the number of shares reported in this column does not include any such securities. Read SEC document
March 08, 2019 Filed Mar 12, 2019 20:24 UTC	PROOFPOINT INC PFPT · Entity 135877	SaleCommon Stock	3,051	$113.85	$347,353.60	Disclosure SEC source: 0001567619-19-006673 · doc1.xml · nonDerivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,783 F1 · shares: Represents the aggregate of sales effected on the same day at different prices. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $113.75 to $113.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
September 25, 2018 Filed Sep 27, 2018 00:03 UTC	BOX INC BOX · Entity 3932	SaleClass A Common Stock	6,000	$23.96	$143,760.00	Disclosure SEC source: 0001209191-18-052373 · doc4.xml · nonDerivative · entry 2 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,251 F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $23.95 to $23.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:03 UTC	BOX INC BOX · Entity 3932	SaleClass A Common Stock	6,000	$23.81	$142,860.00	Disclosure SEC source: 0001209191-18-052373 · doc4.xml · nonDerivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,251 F1 · price: This sale price represents the weighted average sale price of the shares sold ranging from $23.80 to $23.825 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document
July 16, 2018 Filed Jul 18, 2018 23:15 UTC	PROOFPOINT INC PFPT · Entity 135877	GrantCommon Stock	1,687	$0.00	$0.00	Disclosure SEC source: 0001140361-18-032824 · doc1.xml · nonDerivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,834 F1 · shares: Represents an award of restricted stock units ("RSUs"). 100% of the RSUs will vest on May 30, 2019. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. Read SEC document
July 06, 2018 Filed Jul 10, 2018 23:39 UTC	BOX INC BOX · Entity 3932	SaleClass A Common Stock	15,000	$26.11	$391,650.00	Disclosure SEC source: 0001209191-18-042248 · doc4.xml · nonDerivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,251 F1 · price: This sale price represents the weighted average sale price of the shares sold ranging from $26.03 to $26.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document
June 20, 2018 Filed Jun 22, 2018 23:58 UTC	BOX INC BOX · Entity 3932	GrantDirector Stock Option (right to buy) · Derivative	7,398	$0.00 Strike: $29.01	$0.00	Disclosure SEC source: 0001209191-18-039328 · doc4.xml · derivative · entry 2 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,398 Underlying: Class A Common Stock · 7,398 shares Expires 2028-06-20 F2 · derivative.exercise_date: Represents an automatic annual stock option award pursuant to the Issuer's Outside Director Compensation Policy. 100% of the shares subject to the option vest on the earlier of June 20, 2019 or the Issuer's next annual meeting of stockholders. Read SEC document
June 20, 2018 Filed Jun 22, 2018 23:58 UTC	BOX INC BOX · Entity 3932	GrantClass A Common Stock	3,699	$0.00	$0.00	Disclosure SEC source: 0001209191-18-039328 · doc4.xml · nonDerivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,251 F1 · shares: Represents an automatic annual restricted stock unit (RSU) award pursuant to the Issuer's Outside Director Compensation Policy. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. 100% of the RSUs vest on the earlier of June 20, 2019 or the Issuer's next annual meeting of stockholders. Read SEC document
June 14, 2018 Filed Jun 19, 2018 00:19 UTC	BOX INC BOX · Entity 3932	ConversionClass B Common Stock · Derivative	120,653	$0.00	$0.00	Disclosure SEC source: 0001209191-18-038433 · doc4.xml · derivative · entry 2 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 120,653 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: This does not represent a sale or purchase of Issuer's common stock; rather, it represents the automatic conversion of shares of the Issuer's Class B Common Stock into shares of the Issuer's Class A Common Stock, which occurred when outstanding Class B Common Stock no longer represented at least 5% of the Issuer's total outstanding common stock, as set forth in the Issuer's Amended and Restated Certificate of Incorporation. F1 · derivative.exercise_date: This does not represent a sale or purchase of Issuer's common stock; rather, it represents the automatic conversion of shares of the Issuer's Class B Common Stock into shares of the Issuer's Class A Common Stock, which occurred when outstanding Class B Common Stock no longer represented at least 5% of the Issuer's total outstanding common stock, as set forth in the Issuer's Amended and Restated Certificate of Incorporation. F1 · derivative.expiration_date: This does not represent a sale or purchase of Issuer's common stock; rather, it represents the automatic conversion of shares of the Issuer's Class B Common Stock into shares of the Issuer's Class A Common Stock, which occurred when outstanding Class B Common Stock no longer represented at least 5% of the Issuer's total outstanding common stock, as set forth in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document
June 14, 2018 Filed Jun 19, 2018 00:19 UTC	BOX INC BOX · Entity 3932	ConversionClass A Common Stock	120,653	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-18-038433 · doc4.xml · nonDerivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This does not represent a sale or purchase of Issuer's common stock; rather, it represents the automatic conversion of shares of the Issuer's Class B Common Stock into shares of the Issuer's Class A Common Stock, which occurred when outstanding Class B Common Stock no longer represented at least 5% of the Issuer's total outstanding common stock, as set forth in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document
May 29, 2018 Filed May 30, 2018 21:26 UTC	PROOFPOINT INC PFPT · Entity 135877	Exercise / conversionNon-qualified stock option (right to buy) · Derivative	4,163	$0.00 Strike: $4.56	$0.00	Disclosure SEC source: 0001140361-18-026303 · doc1.xml · derivative · entry 2 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,163 shares Expires 2018-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is immediately exercisable in full. Read SEC document
May 29, 2018 Filed May 30, 2018 21:26 UTC	PROOFPOINT INC PFPT · Entity 135877	Exercise / conversionCommon Stock	4,163	$4.56	$18,983.28	Disclosure SEC source: 0001140361-18-026303 · doc1.xml · nonDerivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
January 10, 2018 Filed Jan 13, 2018 00:28 UTC	BOX INC BOX · Entity 3932	ConversionClass B Common Stock · Derivative	7,500	$0.00	$0.00	Disclosure SEC source: 0001209191-18-003480 · doc4.xml · derivative · entry 3 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,653 Underlying: Class A Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · kind: At the Reporting Person's instruction, shares of Class B Common Stock were converted into Class A Common Stock. F3 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document
January 10, 2018 Filed Jan 13, 2018 00:28 UTC	BOX INC BOX · Entity 3932	SaleClass A Common Stock	7,500	$21.15	$158,587.50	Disclosure SEC source: 0001209191-18-003480 · doc4.xml · nonDerivative · entry 2 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,899 F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $21.12 to $21.19 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document
January 10, 2018 Filed Jan 13, 2018 00:28 UTC	BOX INC BOX · Entity 3932	ConversionClass A Common Stock	7,500	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-18-003480 · doc4.xml · nonDerivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,399 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: At the Reporting Person's instruction, shares of Class B Common Stock were converted into Class A Common Stock. F1 · price: At the Reporting Person's instruction, shares of Class B Common Stock were converted into Class A Common Stock. Read SEC document
January 03, 2018 Filed Jan 5, 2018 21:29 UTC	BOX INC BOX · Entity 3932	ConversionClass B Common Stock · Derivative	1,733	$0.00	$0.00	Disclosure SEC source: 0001209191-18-002467 · doc4.xml · derivative · entry 3 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,153 Underlying: Class A Common Stock · 1,733 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · kind: At the Reporting Person's instruction, shares of Class B Common Stock were converted into Class A Common Stock. F3 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document
January 03, 2018 Filed Jan 5, 2018 21:29 UTC	BOX INC BOX · Entity 3932	SaleClass A Common Stock	7,500	$21.65	$162,390.00	Disclosure SEC source: 0001209191-18-002467 · doc4.xml · nonDerivative · entry 2 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,899 F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $21.56 to $21.68 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document
January 03, 2018 Filed Jan 5, 2018 21:29 UTC	BOX INC BOX · Entity 3932	ConversionClass A Common Stock	1,733	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-18-002467 · doc4.xml · nonDerivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,399 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: At the Reporting Person's instruction, shares of Class B Common Stock were converted into Class A Common Stock. F1 · price: At the Reporting Person's instruction, shares of Class B Common Stock were converted into Class A Common Stock. Read SEC document
June 21, 2017 Filed Jun 24, 2017 00:52 UTC	BOX INC BOX · Entity 3932	GrantDirector Stock Option (right to buy) · Derivative	10,764	$0.00 Strike: $18.79	$0.00	Disclosure SEC source: 0001209191-17-041781 · doc4.xml · derivative · entry 2 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,764 Underlying: Class A Common Stock · 10,764 shares Expires 2027-06-21 F2 · derivative.exercise_date: Represents an automatic annual stock option award pursuant to the Issuer's Outside Director Compensation Policy. 100% of the shares subject to the option vest on the earlier of June 21, 2018 or the Issuer's next annual meeting of stockholders. Read SEC document
June 21, 2017 Filed Jun 24, 2017 00:52 UTC	BOX INC BOX · Entity 3932	GrantClass A Common Stock	5,382	$0.00	$0.00	Disclosure SEC source: 0001209191-17-041781 · doc4.xml · nonDerivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,666 F1 · shares: Represents an automatic annual restricted stock unit (RSU) award pursuant to the Issuer's Outside Director Compensation Policy. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. 100% of the RSUs vest on the earlier of June 21, 2018 or the Issuer's next annual meeting of stockholders. Read SEC document
June 12, 2017 Filed Jun 14, 2017 22:20 UTC	PROOFPOINT INC PFPT · Entity 135877	GrantCommon Stock	2,241	$0.00	$0.00	Disclosure SEC source: 0001140361-17-025028 · doc1.xml · nonDerivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,984 F1 · shares: Represents an award of restricted stock units ("RSUs"). 100% of the RSUs will vest on June 1, 2018. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. Read SEC document
May 17, 2017 Filed May 18, 2017 20:11 UTC	Criteo S.A. CRTO · Entity 291	Exercise / conversionNon-employee Warrant (right to buy) · Derivative	10,000	$0.00 Strike: $10.54	$0.00	Disclosure SEC source: 0001576427-17-000104 · wf-form4_149513830179853.xml · derivative · entry 9 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 Underlying: Ordinary Shares · 10,000 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.54 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926) F7 · derivative.exercise_date: One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document
May 17, 2017 Filed May 18, 2017 20:11 UTC	Criteo S.A. CRTO · Entity 291	SaleOrdinary Shares	10,000	$44.60	$446,000.00	Disclosure SEC source: 0001576427-17-000104 · wf-form4_149513830179853.xml · nonDerivative · entry 6 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F6 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.60 to $44.66, inclusive. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document
May 17, 2017 Filed May 18, 2017 20:11 UTC	Criteo S.A. CRTO · Entity 291	Exercise / conversionOrdinary Shares	10,000	$10.54	$105,400.00	Disclosure SEC source: 0001576427-17-000104 · wf-form4_149513830179853.xml · nonDerivative · entry 5 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · price: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.54 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926) F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document
May 16, 2017 Filed May 18, 2017 20:11 UTC	Criteo S.A. CRTO · Entity 291	Exercise / conversionNon-employee Warrant (right to buy) · Derivative	10,300	$0.00 Strike: $10.54	$0.00	Disclosure SEC source: 0001576427-17-000104 · wf-form4_149513830179853.xml · derivative · entry 8 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,300 Underlying: Ordinary Shares · 10,300 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.54 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926) F7 · derivative.exercise_date: One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document
May 16, 2017 Filed May 18, 2017 20:11 UTC	Criteo S.A. CRTO · Entity 291	Exercise / conversionNon-employee Warrant (right to buy) · Derivative	3,866	$0.00 Strike: $44.82	$0.00	Disclosure SEC source: 0001576427-17-000104 · wf-form4_149513830179853.xml · derivative · entry 7 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,864 Underlying: Ordinary Shares · 3,866 shares Expires 2025-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 41.02 euros. The U.S. dollar equivalent of the exercise price is $44.82 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926) F7 · derivative.exercise_date: One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document
May 16, 2017 Filed May 18, 2017 20:11 UTC	Criteo S.A. CRTO · Entity 291	SaleOrdinary Shares	10,300	$51.94	$534,982.00	Disclosure SEC source: 0001576427-17-000104 · wf-form4_149513830179853.xml · nonDerivative · entry 4 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.80 to $52.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote (6) to this Form 4. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document
May 16, 2017 Filed May 18, 2017 20:11 UTC	Criteo S.A. CRTO · Entity 291	Exercise / conversionOrdinary Shares	10,300	$10.54	$108,562.00	Disclosure SEC source: 0001576427-17-000104 · wf-form4_149513830179853.xml · nonDerivative · entry 3 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · price: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.54 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926) F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document
May 16, 2017 Filed May 18, 2017 20:11 UTC	Criteo S.A. CRTO · Entity 291	SaleOrdinary Shares	3,866	$51.94	$200,800.04	Disclosure SEC source: 0001576427-17-000104 · wf-form4_149513830179853.xml · nonDerivative · entry 2 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.80 to $52.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote (6) to this Form 4. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document
May 16, 2017 Filed May 18, 2017 20:11 UTC	Criteo S.A. CRTO · Entity 291	Exercise / conversionOrdinary Shares	3,866	$44.82	$173,274.12	Disclosure SEC source: 0001576427-17-000104 · wf-form4_149513830179853.xml · nonDerivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the non-employee warrant is 41.02 euros. The U.S. dollar equivalent of the exercise price is $44.82 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926) F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document
December 05, 2016 Filed Dec 6, 2016 22:41 UTC	Everyday Health, Inc. EVDY · Entity 180558	Disposition to issuerStock Option (Right to Buy) · Derivative	83,333	$5.91 Strike: $4.59	$492,498.03	Disclosure SEC source: 0001209191-16-153718 · doc4.xml · derivative · entry 6 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 83,333 shares Expires not disclosed F3 · kind: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). F3 · price: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). Read SEC document
December 05, 2016 Filed Dec 6, 2016 22:41 UTC	Everyday Health, Inc. EVDY · Entity 180558	Disposition to issuerStock Option (Right to Buy) · Derivative	23,333	$1.64 Strike: $8.87	$38,149.46	Disclosure SEC source: 0001209191-16-153718 · doc4.xml · derivative · entry 5 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,333 shares Expires not disclosed F3 · kind: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). F3 · price: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). Read SEC document
December 05, 2016 Filed Dec 6, 2016 22:41 UTC	Everyday Health, Inc. EVDY · Entity 180558	Disposition to issuerStock Option (Right to Buy) · Derivative	23,333	$4.16 Strike: $6.35	$96,948.62	Disclosure SEC source: 0001209191-16-153718 · doc4.xml · derivative · entry 4 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,333 shares Expires not disclosed F3 · kind: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). F3 · price: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). Read SEC document
December 05, 2016 Filed Dec 6, 2016 22:41 UTC	Everyday Health, Inc. EVDY · Entity 180558	Disposition to issuerStock Option (Right to Buy) · Derivative	20,333	$2.82 Strike: $7.68	$57,339.06	Disclosure SEC source: 0001209191-16-153718 · doc4.xml · derivative · entry 3 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,333 shares Expires not disclosed F3 · kind: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). F3 · price: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, this option was cancelled and converted into the right to receive cash consideration of $10.50 per share subject to such stock option less the exercise price payable per share (without interest and less any applicable tax withholding). Read SEC document
December 05, 2016 Filed Dec 6, 2016 22:41 UTC	Everyday Health, Inc. EVDY · Entity 180558	Disposition to issuerCommon Stock	16,375	$10.50	$171,937.50	Disclosure SEC source: 0001209191-16-153718 · doc4.xml · nonDerivative · entry 2 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Pursuant to the terms of the award, the vesting of restricted stock units for an aggregate of 16,375 shares was accelerated in connection with the Merger. Pursuant to the terms of the Merger Agreement, these accelerated restricted stock units were cancelled and converted into the right to receive cash consideration of $10.50 per share (without interest and less any applicable tax withholding). F2 · price: Pursuant to the terms of the award, the vesting of restricted stock units for an aggregate of 16,375 shares was accelerated in connection with the Merger. Pursuant to the terms of the Merger Agreement, these accelerated restricted stock units were cancelled and converted into the right to receive cash consideration of $10.50 per share (without interest and less any applicable tax withholding). Read SEC document
December 03, 2016 Filed Dec 6, 2016 22:41 UTC	Everyday Health, Inc. EVDY · Entity 180558	OtherCommon Stock	2,008	$10.50	$21,084.00	Disclosure SEC source: 0001209191-16-153718 · doc4.xml · nonDerivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,375 F1 · kind: Disposed of pursuant to a cash tender offer conducted in accordance with the Agreement and Plan of Merger (the "Merger Agreement"), dated October 21, 2016, among the Issuer, Ziff Davis, LLC, a Delaware limited liability company (the "Parent"), Project Echo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") and j2 Global, Inc. in exchange for cash consideration of $10.50 per share, without interest and less any applicable tax withholding. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). F1 · price: Disposed of pursuant to a cash tender offer conducted in accordance with the Agreement and Plan of Merger (the "Merger Agreement"), dated October 21, 2016, among the Issuer, Ziff Davis, LLC, a Delaware limited liability company (the "Parent"), Project Echo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") and j2 Global, Inc. in exchange for cash consideration of $10.50 per share, without interest and less any applicable tax withholding. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). Read SEC document
October 27, 2016 Filed Oct 28, 2016 20:12 UTC	Criteo S.A. CRTO · Entity 291	GrantNon-employee Warrant (right to buy) · Derivative	13,185	$0.00 Strike: $36.92	$0.00	Disclosure SEC source: 0001576427-16-000378 · wf-form4_147768550658129.xml · derivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,185 Underlying: Ordinary Shares · 13,185 shares Expires 2026-10-27 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 33.98 euros. The U.S. dollar equivalent of the exercise price is $36.92 using the Federal Reserve Bank of New York noon buying rate for October 21, 2016 (1.00 = $1.0866) F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.